Oct 12, 2016· Comment from National Community Pharmacists Association (NCPA)· FDA-2016-D-1309-0084
Attached please find comments submitted by the National Community Pharmacists Association (NCPA).
FDANonrulemakingFDA-2016-D-1309
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability
RIN
—
Last modified
Oct 21, 2019
Comment window
closed 3080d ago
National Community Pharmacists Association filings
1
Activity
National Community Pharmacists Association filed 1 comment on this docket between Oct 12, 2016 and Oct 12, 2016. 10 other organizations filed here. The comment window closed 3080d ago.
What National Community Pharmacists Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (10)
See everyone who commented →- National Community Pharmacists AssociationTHIS ORG1 filing · confidence 97%
- National Consumers Leaguetrade assoc.2 filings · confidence 85%
- National Home Infusion Associationtrade assoc.2 filings · confidence 85%
- & Jacobs Institute of Women's Healthtrade assoc.1 filing · confidence 85%
- American Academy of Dermatology Associationtrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Society of Anesthesiologiststrade assoc.1 filing · confidence 85%
- California Life Sciences Associationtrade assoc.1 filing · confidence 85%
- HealthCare Institute of New Jerseytrade assoc.1 filing · confidence 85%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%
- Texas Healthcare & Bioscience Institutetrade assoc.1 filing · confidence 85%